$DTM

Goldman Sachs cuts DT Midstream stock price target on project timing

Goldman Sachs reduced its price target for DT Midstream (NYSE:DTM) to $121 from $127, maintaining a Sell rating. The stock is currently trading at $126.55, which is considered overvalued relative to its Fair Value estimate. Goldman expects Q3 2026 EBITDA of $300 million, in line with consensus. Full-year 2026 EBITDA is forecasted at $1,221 million, slightly above consensus. The firm noted a 13% stock decline over the past three months, reflecting growth timing concerns.

Original reporting
Published Oct 14, 2026, 9:46 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 14, 2026, 10:03 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$DTM
Bearish
high confidence
Mentioned
$DTM
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$DTMBearishMed
01

Why it matters

The downgrade may trigger short-term selling pressure, but competing analyst upgrades could create a split view.

02

Market read

Analyst target cut on DT Midstream provides a fresh bearish signal for the stock and may influence peer midstream equities.

03

What to watch

Recent FID completions on $300 M organic projects could improve cash flow beyond current estimates.

Relevance 7/10Novelty 7/10Timing: pre-market today

Background

Goldman Sachs' coverage change follows DT Midstream's Q2 results and project updates, highlighting valuation concerns.

Company-level read

Ticker impact

$DTMBearishHigh confidence
Context

Goldman Sachs lowered its price target on DT Midstream to $121 and kept a Sell rating, citing overvaluation and slower project timing.

Expected impact

likely pressure as investors price in the lower target and slower growth expectations

Evidence & confidence

Target reduction from $127 to $121 signals a bearish view; the stock is already near the prior target, so a pullback is plausible.

Market effects

May weigh on other midstream and natural gas transmission stocks as analysts reassess project timing.

Limited to U.S. energy sector, no broader regional effect.

Low global impact; primarily a U.S. midstream company.

Counterpoint

Wolfe Research upgraded DTM to Outperform with a $145 target, indicating potential upside if projects accelerate.

Key entities

  • Goldman Sachs

    Reduced DTM price target to $121, maintaining Sell rating.

  • Wolfe Research

    Upgraded DTM to Outperform with a $145 price target.

Related articles

$ARGXMed

Here Are Wednesday’s Top Wall Street Analyst Research Calls: Atlassian, Dick’s Sporting Goods, EPAM Systems, GoDaddy, Intuit, Jersey Mike’s Subs, JFrog, Lattice Semiconductor, and More

Wall Street analysts issued upgrades, downgrades, and initiations for several companies. Upgrades include argenx (ARGX) to Buy at UBS, DT Midstream (DTM) to Outperform at Wolfe Research, and SolarEdge (SEDG) to Buy at UBS. Downgrades include Dick's Sporting Goods (DKS) to Hold at Truist, EPAM Systems (EPAM) to Neutral at JPMorgan, and Intuit (INTU) to Neutral at Bank of America. Initiations include Atlassian (TEAM) with Outperform at RBC, JFrog (FROG) with Outperform at RBC, and Lattice Semicond

$WMBMed

Midstream Companies Expand Natural Gas Pipelines as LNG & AI Demand Grows

Williams Companies (WMB) will buy Momentum Midstream for $5.5B and invest $1.5B in its Delta Access Expansion, adding 4.05 Bcf/d capacity and 2.25 Bcf/d starting early 2029. Enbridge (ENB) and MPLX (MPLX) sanctioned the 2.6 Bcf/d Bay Runner Twin Pipeline for NextDecade’s Rio Grande LNG, entering service by 2030. TC Energy (TRP) and DT Midstream (DTM) approved gas pipeline expansions tied to 20-year take-or-pay contracts for power and AI data centers.